| Company | Aug 25 | Sep 25 | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | 12-Mo |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TXRH | -7% | -3% | -2% | +7% | -5% | +8% | +2% | -9% | -3% | +12% | +7% | +6% | +13% |
| PTLO | -29% | -9% | -17% | -2% | -13% | +24% | -5% | -1% | +18% | -31% | +10% | -4% | -54% |
| WEN | +8% | -13% | -7% | -1% | +0% | -6% | -2% | -8% | +0% | +11% | +10% | -11% | -20% |
| BLMN | -18% | -2% | -5% | +4% | -13% | -3% | +2% | -12% | +13% | +38% | +8% | -5% | -3% |
Source: Yahoo Finance monthly adjusted close.
Quick Thesis
- Rated Sell because leverage and negative free cash flow still dominate the equity case.
- Best support is Q1 2026 revenue of $378.3M and EBITDA of $20.9M.
- Biggest risk is $502.4M of debt against $22M of operating cash flow and a 0.71x current ratio.
- Valuation looks cheap on 0.6x EV/revenue, but not on 11.6x EV/EBITDA or 35.8x forward P/E.
- I would turn more constructive if quarterly EBITDA stays above $25M and refinancing is secured.
Executive Summary
Rating: SELL | RRGB
Measured from adjusted close on 2026-08-19 to 2026-08-19. Sell ratings are correct when the stock falls; Hold is tracked as a +/-10% range. Daily-close data, not intraday. Calls are tracked for 182 days from publication, then frozen as a final record.
I would put my rating as a Sell because Red Robin still has not shown me that the recent revenue rebound is durable enough to offset an 8.3x net debt/EBITDA load and negative levered free cash flow. The Q1 2026 bounce to $378.3M of revenue and $20.9M of EBITDA is encouraging, but it does not yet prove that the First Choice plan is converting traffic into sustained earnings power. In my view, the stock is being helped by sentiment more than fundamentals, especially with a 0.71x current ratio and $22M of TTM operating cash flow against $20.4M of levered free cash flow outflow. I would raise my rating more towards a Hold if quarterly EBITDA stays above $25M, meaning the business is consistently generating enough operating profit to fund itself and reduce refinancing risk.
Company Profile
Red Robin Gourmet Burgers, Inc. was formed in 2001 and completed its initial public offering in 2002, listing on Nasdaq under RRGB. The company opened its first restaurant in Seattle in 1969 and its first franchised unit in Yakima in 1979, so it has a long operating history before the public-company era.
As of fiscal year-end 2025, Red Robin operated 475 restaurants in North America, including 385 company-owned locations across 39 states and 90 franchised restaurants across 13 states and 1 Canadian province. It earns revenue from company-operated restaurant sales and from franchise royalties and advertising fund contributions. Donatos pizza, a licensed pizza brand, is offered in 260 restaurants. Red Robin International, Inc. is the operating subsidiary, and the company had 18,852 team members at December 28, 2025.
Economic Moat
Business Model
The Red Robin Royalty database, with about 16.4 million members, is the clearest structural asset in the business because it gives the company a direct channel to target repeat visits, personalize offers, and measure guest behavior in a way I feel is hard to rebuild quickly. That database is tied to years of transaction history and loyalty participation, so it is more than a marketing list; it is a live customer-data asset.
A second support is the franchise system, where 90 franchised restaurants in 13 states and 1 Canadian province provide royalty income and extend brand reach. Donatos, launched in 2020 as a nested pizza offering inside Red Robin restaurants, adds menu differentiation at 260 locations. The menu breadth and family-oriented format help, but I view them as supporting features rather than the core defense.
Business & Operating Risks
The most important disclosed risk is refinancing. Red Robin carries about $170.2M of total borrowings, and the November 2025 Fourth Amendment only pushed the term loan and revolving credit facility maturities to September 3, 2027. That leaves the company dependent on future cash flow and credit-market conditions to avoid a tighter financing outcome.
Execution risk is also real. The First Choice plan is meant to support traffic, sales, debt reduction, and lower expenses, but the filing also warns that those initiatives may not deliver the expected increase in traffic or higher sales. Competition from better-burger concepts and larger restaurant chains adds pressure, while weaker consumer demand would spread fixed costs over a smaller sales base.
Taken together, these risks do not break the loyalty moat itself, but they do threaten the economics that are supposed to make that moat valuable. In my view, the refinancing wall is the more direct threat because it can force the company to monetize assets before the operating reset fully works.
Management Discussion & Analysis
Management is trying to respond to the refinancing and execution risks through refranchising, leadership changes, and a tighter operating plan. The company’s recent actions suggest it is trying to lighten the asset base before the September 2027 maturity becomes more binding, although the balance sheet is still the central constraint.
David Pace became chief executive officer in April 2025, and the First Choice strategic plan replaced North Star in July 2025. Christopher Meyer became interim chief financial officer in December 2025, Humera Kassem became chief people officer in September 2025, and Jesse Griffith became chief operations officer in November 2025. That sequence tells me management is trying to pair a strategy reset with a more operationally disciplined bench, not just announce a new plan and hope for the best.
Recent Events
The most important recent development is the May 27, 2026 refranchising deal, under which Red Robin International agreed to sell assets tied to 30 company-owned restaurants in Washington and Idaho to Evergreen Dining for $23.5M in cash. The locations are expected to reopen as franchised units, so the transaction should improve the mix toward a lighter-asset model even if it does not solve leverage by itself.
I also view the April 29, 2026 CFO change as constructive. Mark Graff, who previously led a $900M business at Bloomin’ Brands, is set to take over as chief financial officer on May 31, 2026, replacing interim CFO Christopher Meyer. In my view, that adds capital-allocation experience at a time when the company needs to manage refranchising and refinancing together.
The legal and governance updates are less material individually, but they still point in the same direction. Sarah Mussetter resigned as chief legal officer and secretary on April 27, 2026, and the May 14, 2026 annual meeting showed broad shareholder support for the board and the employee stock purchase plan. Recent events therefore support the restructuring effort, but they do not yet change the fact that the balance sheet remains the key test.
Financial Analysis
Growth
RRGB — Financial Growth (Quarterly, USD Mil)
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|---|
| REVENUE (USD Mil) | 392.4 | 283.7 | 265.1 | 269 | 378.3 |
| EBIT (USD Mil) | 9.3 | 9.8 | -12.1 | -4 | 5.6 |
| EBITDA (USD Mil) | 24.7 | 21.4 | -0.1 | 8.1 | 20.9 |
| NET INCOME (USD Mil) | 1.2 | 4 | -18.4 | -10.1 | -2.2 |
| DILUTED EPS | 0.1 | 0.2 | -1 | -0.6 | -0.1 |
Source: Yahoo Finance — Quarterly Financial Statements
Revenue fell from $392.4M in Q1 2025 to $283.7M in Q2 2025 and $265.1M in Q3 2025 before recovering to $378.3M in Q1 2026. That rebound matters, but I would not overread it yet because EBITDA was still volatile, moving from $24.7M in Q1 2025 to negative $0.1M in Q3 2025 and then back to $20.9M in Q1 2026. The pattern looks more like a sharp reset than a clean growth trend, which means the operating base is still fragile.
Profitability
RRGB — Profitability (TTM)
| Metric | TTM |
|---|---|
| Operating Margin (TTM) | 2.8% |
| Net Margin (TTM) | -2.5% |
| Return on Assets (TTM) | 1.0% |
| Return on Equity (TTM) | — |
| Gross Margin (TTM) | 14.5% |
| EBITDA Margin (TTM) | 4.9% |
Source: Yahoo Finance — Trailing Twelve Months (TTM)
TTM gross margin was 14.5%, EBITDA margin was 4.9%, and operating margin was 2.8%. The gap between gross margin and operating margin tells me fixed restaurant overhead is still absorbing too much of the sales base, so scale and labor efficiency matter more here than food cost alone.
Net margin was -2.5% TTM, while return on assets was 1.0% TTM. That combination says the asset base is being used better than the income statement would suggest, but not well enough to produce durable bottom-line profit. The Q1 2026 EBITDA rebound is encouraging, yet it still has to flow through to positive net income before I would call the margin repair complete.
Valuation
RRGB — Valuation Multiples
| Metric | Value |
|---|---|
| Forward P/E | 35.8 |
| EV/Revenue | 0.6 |
| EV/EBITDA | 11.6 |
| Analyst Target Price – Low (USD) | 9.5 |
| Analyst Target Price – Mean (USD) | 11.3 |
| Analyst Target Price – High (USD) | 14.5 |
Source: Yahoo Finance
RRGB trades at 0.6x EV/revenue, 0.2x price/sales, 11.6x EV/EBITDA, and 35.8x forward P/E on forward EPS of 0.3. On one hand, that sales multiple looks cheap; on the other, the company is still carrying negative FCF yield of -10.8% and an 8.3x net debt/EBITDA load, so the low revenue multiple is doing a lot of work.
On the analysis here, I would put fair value in a wide range of roughly $18-$130 per share if I simply apply the peer EV/revenue span to Red Robin’s revenue base, but that range is not a clean consensus signal. Analyst coverage is thin at 3 opinions, with targets of $9.5-$$14.5 and a mean of $11.3, so my range sits well above the consensus mean and even above the high target. I think that gap reflects the market’s willingness to pay for a recovery that is not yet visible in the cash flow.
Forward EPS of 0.3 also looks weak relative to the peer set, especially against TXRH’s $7.8 and SHAK’s $1.4. On a like-for-like basis, Red Robin is not cheap on earnings power; it is only cheap if the market believes the current margin structure can improve materially.
Leverage
RRGB — Leverage & Coverage (Quarterly)
| Metric | Value |
|---|---|
| Total Debt/Equity % (mrq) | — |
| Current Ratio (mrq) | 0.7 |
| Total Debt (mrq, USD Mil) | 502.4 |
| Operating Cash Flow (TTM, USD Mil) | 22 |
| Levered Free Cash Flow (TTM, USD Mil) | -20.4 |
| Net Debt/EBITDA (TTM) | 8.3 |
| FCF Margin % (TTM) | -1.7% |
Source: Yahoo Finance — Quarterly Financial Statements
Total debt was $502.4M mrq, current ratio was 0.7x, and net debt/EBITDA was 8.3x TTM. Operating cash flow was $22M TTM, but levered free cash flow was $20.4M and FCF margin was -1.7%, so EBITDA is still not converting into cash after interest and capex.
That matters because the company’s refinancing window is now the real constraint on equity value. A business with this much debt can survive a weak quarter if cash generation is strong; Red Robin does not have that cushion yet. I would want to see leverage move below 6.0x net debt/EBITDA, meaning debt is falling to a level that gives the company room to refinance on better terms rather than simply roll the problem forward.
Insider Activity
The insider record is one-sided selling. The table shows sales by the chief financial officer, chief legal officer, and chief operations officer, and the summary data indicates 21 open-market sales and no open-market purchases in the 2025-03-14 to 2026-05-15 window.
I do not read that as a decisive signal on its own, but it does not give me comfort when the balance sheet is already tight. In a name with negative free cash flow and a 2027 maturity wall, insider buying would have been more helpful than repeated selling.
Comparable Analysis
Growth
| Company | Revenue TTM (USD Mil) | Revenue Growth YoY % | EBITDA TTM (USD Mil) | Diluted EPS TTM |
|---|---|---|---|---|
| RRGB | 1,190.1 | -2.1% | 57.9 | -1.7 |
| TXRH | 6,231.5 | 11.1% | 705.4 | 6.2 |
| SHAK | 1,552.3 | 17.2% | 172.4 | 0.9 |
| PTLO | 748.8 | 5.6% | 77 | 0.2 |
| WEN | 2,203.7 | 1.7% | 455.9 | 0.7 |
| BLMN | 3,979.5 | 1.3% | 316.7 | 0.3 |
Source: Yahoo Finance
RRGB’s revenue fell 2.1% TTM and diluted EPS was -1.7, while TXRH grew revenue 11.1% with EPS of 6.2, SHAK grew 17.2% with EPS of 0.9, PTLO grew 5.6% with EPS of 0.2, WEN grew 1.7% with EPS of 0.7, and BLMN grew 1.3% with EPS of 0.3. The growth gap is wide enough that I do not think Red Robin deserves a premium multiple until it shows it can at least stabilize the top line.
Valuation
| Company | Trailing P/E | Forward P/E | EV/Revenue | EV/EBITDA | Price/Sales (TTM) | Price/Book (mrq) | Beta (5Y Monthly) | FCF Yield % (TTM) | Forward EPS | Analyst Target Price – Low | Analyst Target Price – Mean | Analyst Target Price – High | # Analyst Opinions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RRGB | — | 35.8 | 0.6 | 11.6 | 0.2 | -1.7 | 2.43 | -10.8% | 0.3 | 9.5 | 11.3 | 14.5 | 3 |
| TXRH | 32.9 | 26.4 | 2.3 | 20.2 | 2.2 | 8.8 | 0.80 | 1.8% | 7.8 | 125 | 217.7 | 276 | 23 |
| SHAK | 78 | 53 | 2.3 | 20.5 | 2 | 5.5 | 1.66 | -1.3% | 1.4 | 60 | 82.2 | 126 | 23 |
| PTLO | 27.1 | 21 | 1.4 | 13.6 | 0.5 | 0.7 | 1.57 | -11.1% | 0.2 | 5 | 6.2 | 11 | 10 |
| WEN | 13.5 | 16.3 | 2.4 | 11.7 | 0.8 | — | 0.38 | 10.2% | 0.5 | 5 | 7.8 | 13 | 19 |
| BLMN | 33.6 | 10.4 | 0.7 | 8.8 | 0.2 | 2.1 | 1.20 | 30.0% | 1 | 6 | 11.3 | 15 | 11 |
Source: Yahoo Finance
RRGB trades at 0.6x EV/revenue, 11.6x EV/EBITDA, and 0.2x price/sales, versus TXRH at 2.3x, 20.2x, and 2.2x, SHAK at 2.3x, 20.5x, and 2.0x, PTLO at 1.4x, 13.6x, and 0.5x, WEN at 2.4x, 11.7x, and 0.8x, and BLMN at 0.7x, 8.8x, and 0.2x. The market is clearly not paying Red Robin for growth, and I think that is fair given the negative FCF yield and the leverage profile.
A useful cross-check is that RRGB’s low sales multiple does not come with balance-sheet safety. TXRH’s higher valuation is supported by 1.3x net debt/EBITDA and positive FCF, while Red Robin’s 8.3x leverage and negative FCF make its discount look more like a risk adjustment than a mispricing.
Profitability
| Company | Operating Margin (TTM) | Net Margin (TTM) | Return on Assets (TTM) | Return on Equity (TTM) | Gross Margin (TTM) | EBITDA Margin (TTM) |
|---|---|---|---|---|---|---|
| RRGB | 2.8% | -2.5% | 1.0% | — | 14.5% | 4.9% |
| TXRH | 8.5% | 6.6% | 8.7% | 27.7% | 16.2% | 11.3% |
| SHAK | 5.1% | 2.6% | 2.0% | 7.9% | 40.4% | 11.1% |
| PTLO | 8.4% | 1.9% | 1.8% | 2.7% | 20.8% | 10.3% |
| WEN | 14.3% | 5.7% | 3.8% | 108.0% | 33.1% | 20.7% |
| BLMN | 4.4% | 0.7% | 2.6% | 8.1% | 13.6% | 8.0% |
Source: Yahoo Finance
RRGB’s 2.8% operating margin, -2.5% net margin, 1.0% ROA, 14.5% gross margin, and 4.9% EBITDA margin trail TXRH’s 8.5%, 6.6%, 8.7%, 16.2%, and 11.3%, SHAK’s 5.1%, 2.6%, 2.0%, 40.4%, and 11.1%, PTLO’s 8.4%, 1.9%, 1.8%, 20.8%, and 10.3%, WEN’s 14.3%, 5.7%, 3.8%, 33.1%, and 20.7%, and BLMN’s 4.4%, 0.7%, 2.6%, 13.6%, and 8.0%. The gross margin gap is not the main issue; the real problem is that Red Robin converts too little of that gross profit into operating income.
That is why the peer comparison matters for the moat as well. The loyalty asset and refranchising strategy can support traffic, but until operating margin moves closer to the peer range, the structural advantage is not showing up in the numbers.
Leverage
| Company | Current Ratio (mrq) | Operating Cash Flow TTM (USD Mil) | Net Debt/EBITDA (TTM) | FCF Margin % (TTM) |
|---|---|---|---|---|
| RRGB | 0.7 | 22 | 8.3 | -1.7% |
| TXRH | 0.5 | 803.3 | 1.3 | 3.8% |
| SHAK | 1.7 | 191.6 | 3.7 | -2.7% |
| PTLO | 0.3 | 78.3 | 8.7 | -5.2% |
| WEN | 1.9 | 358.5 | 8.2 | 7.9% |
| BLMN | 0.3 | 319.8 | 5.9 | 6.9% |
Source: Yahoo Finance
RRGB’s current ratio is 0.7x, total debt is $502.4M, operating cash flow is $22M, free cash flow is $20.4M, and net debt/EBITDA is 8.3x. TXRH is much cleaner at 1.3x net debt/EBITDA and 3.8% FCF margin, while WEN and BLMN also generate positive FCF margins of 7.9% and 6.9%.
The leverage gap explains part of the valuation gap. Investors are paying for balance-sheet flexibility at the better names, not just for higher growth, and Red Robin has not earned that premium yet.
Conclusion
I would put my rating as a Sell because the key tension is still unresolved: Red Robin has shown a revenue rebound, but it has not yet shown me that the rebound is strong enough to repair leverage and cash flow at the same time. The Q1 2026 improvement to $378.3M of revenue and $20.9M of EBITDA is real, yet the company still posted negative net income, negative levered free cash flow, and an 8.3x net debt/EBITDA ratio.
I would raise my rating more towards a Hold if quarterly EBITDA stays above $25M, meaning the business is consistently generating enough operating profit to support itself, and if levered free cash flow turns positive, meaning the turnaround is actually funding the balance sheet. A cleaner bull case would also include net debt/EBITDA moving below 6.0x, which would show the September 2027 maturity is becoming manageable on better terms rather than just being rolled forward. If the Washington and Idaho refranchising proceeds help push that leverage lower, the equity would deserve a better multiple than 0.6x EV/revenue.
I would move from Sell to Strong Sell if refinancing closes off or comes back at punitive terms, because the current $502.4M debt load against only $22M of operating cash flow leaves very little room for error. Another negative trigger would be a return to negative EBITDA, since that would tell me the operating reset is not holding and the balance sheet would again be absorbing losses instead of bridging to recovery.
Weighing both sides, I think the bear case is more likely to show up first because the company still has to prove that the recent quarter was the start of sustained margin repair rather than a short-lived rebound. The stock can keep moving on sentiment, but I would rather see cash flow and leverage improve before treating the rally as durable.
What to Watch Next
- Quarterly EBITDA above $25M — would support a move toward Hold.
- Levered free cash flow turning positive — would show the reset is funding itself.
- Net debt/EBITDA below 6.0x — would improve refinancing flexibility.
- Progress on the September 2027 maturity — would reduce balance-sheet overhang.
- Refranchising proceeds flowing into lower leverage — would strengthen the equity case.
What’s your take? I rated Red Robin (RRGB) SELL above — but the goal here is to get this right, not just to publish an opinion. What would you add to this analysis, or which risk or catalyst do you think I’m under- or over-weighting? Tell me in the comments.
Sources
- SEC 10-K Annual Report — filed 2026-02-25
- SEC 8-K Filing (2026-05-28)
- SEC 8-K Filing (2026-05-19)
- SEC 8-K Filing (2026-05-15)
- SEC 8-K Filing (2026-05-01)
- SEC 8-K Filing (2026-04-30)
- SEC 8-K Filing (2026-02-25)
- SEC Form 4 Insider Transaction (2026-05-15)
- SEC Form 4 Insider Transaction (2026-05-15)
- SEC Form 4 Insider Transaction (2026-05-15)
- SEC 10-K Annual Report — FY2026
- SEC 10-K Annual Report — FY2025
- SEC 10-K Annual Report — FY2024
- SEC 10-K Annual Report — FY2023
- SEC 10-K Annual Report — FY2022
Data sourced from Yahoo Finance and SEC EDGAR. Not investment advice.
Leave a Comment